EUVIMEDEUVIMED entdecken
Crossref

Review of Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Austin Wesevich

Evidence to Action: Official Journal of MDCalc · 15.05.2026 · 012026 (01)

DOI: 10.65357/001c.158530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Evidence to Action: Official Journal of MDCalc, online erschienen am 15.05.2026. Verfasst von Austin Wesevich.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American Society for Transplantation and Cellular Therapy (ASTCT) developed this consensus grading system based on prior Common Terminology Criteria for Adverse Events (CTCAE) and Immune Effector Cells Therapy Toxicity Assessment and Management (CARTOX) grading systems. Grade of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) should guide management.

Zitieren

APA

Wesevich, A. (2026). Review of Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS). Evidence to Action: Official Journal of MDCalc, 012026(01). https://doi.org/10.65357/001c.158530

Vancouver

Wesevich A. Review of Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS). Evidence to Action: Official Journal of MDCalc. 2026;012026(01). doi:10.65357/001c.158530

BibTeX
@article{Wesevich2026,
  author = {Wesevich, Austin},
  title = {Review of Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS)},
  journal = {Evidence to Action: Official Journal of MDCalc},
  year = {2026},
  volume = {012026},
  number = {01},
  doi = {10.65357/001c.158530}
}
Kostenlos starten →